ATNM
Price
$1.60
Change
+$0.01 (+0.63%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
50.23M
58 days until earnings call
OXBDF
Price
$7.91
Change
-$0.35 (-4.24%)
Updated
Sep 24 closing price
Capitalization
926.35M
Interact to see
Advertisement

ATNM vs OXBDF

Header iconATNM vs OXBDF Comparison
Open Charts ATNM vs OXBDFBanner chart's image
Actinium Pharmaceuticals
Price$1.60
Change+$0.01 (+0.63%)
Volume$1.53K
Capitalization50.23M
Oxford Biomedica
Price$7.91
Change-$0.35 (-4.24%)
Volume$100
Capitalization926.35M
ATNM vs OXBDF Comparison Chart in %
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OXBDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. OXBDF commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Buy and OXBDF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ATNM: $1.60 vs. OXBDF: $7.91)
Brand notoriety: ATNM and OXBDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 37% vs. OXBDF: 9%
Market capitalization -- ATNM: $49.6M vs. OXBDF: $945.81M
ATNM [@Biotechnology] is valued at $49.6M. OXBDF’s [@Biotechnology] market capitalization is $945.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileOXBDF’s FA Score has 0 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • OXBDF’s FA Score: 0 green, 5 red.
According to our system of comparison, OXBDF is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 3 TA indicator(s) are bullish while OXBDF’s TA Score has 2 bullish TA indicator(s).

  • ATNM’s TA Score: 3 bullish, 6 bearish.
  • OXBDF’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, OXBDF is a better buy in the short-term than ATNM.

Price Growth

ATNM (@Biotechnology) experienced а +0.50% price change this week, while OXBDF (@Biotechnology) price change was +1.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

ATNM is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OXBDF($926M) has a higher market cap than ATNM($50.2M). OXBDF YTD gains are higher at: 46.525 vs. ATNM (26.825).
ATNMOXBDFATNM / OXBDF
Capitalization50.2M926M5%
EBITDA-43.43MN/A-
Gain YTD26.82546.52558%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash59.9MN/A-
Total Debt1.29MN/A-
FUNDAMENTALS RATINGS
ATNM vs OXBDF: Fundamental Ratings
ATNM
OXBDF
OUTLOOK RATING
1..100
396
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
7937
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATNM's Valuation (70) in the Biotechnology industry is in the same range as OXBDF (78) in the null industry. This means that ATNM’s stock grew similarly to OXBDF’s over the last 12 months.

ATNM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as OXBDF (100) in the null industry. This means that ATNM’s stock grew similarly to OXBDF’s over the last 12 months.

OXBDF's SMR Rating (95) in the null industry is in the same range as ATNM (99) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to ATNM’s over the last 12 months.

OXBDF's Price Growth Rating (37) in the null industry is somewhat better than the same rating for ATNM (79) in the Biotechnology industry. This means that OXBDF’s stock grew somewhat faster than ATNM’s over the last 12 months.

OXBDF's P/E Growth Rating (98) in the null industry is in the same range as ATNM (100) in the Biotechnology industry. This means that OXBDF’s stock grew similarly to ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNMOXBDF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
54%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 16 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 4 days ago
53%
Aroon
ODDS (%)
Bearish Trend 5 days ago
84%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OXBDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MVCJX32.330.39
+1.22%
MFS Mid Cap Value R4
TRRPX18.060.18
+1.01%
Nuveen Real Estate Sec Sel Premier
LMIRX21.780.21
+0.97%
Franklin International Equity R
IGIIX43.210.21
+0.49%
Macquarie Global Growth Fund Class I
CGVIX15.430.05
+0.33%
Causeway Global Value Inst

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with IPSC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
+0.50%
IPSC - ATNM
46%
Loosely correlated
+4.41%
CRBU - ATNM
44%
Loosely correlated
+10.36%
RXRX - ATNM
43%
Loosely correlated
+2.05%
HLVX - ATNM
40%
Loosely correlated
N/A
CRSP - ATNM
39%
Loosely correlated
+2.24%
More

OXBDF and

Correlation & Price change

A.I.dvisor tells us that OXBDF and SER have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OXBDF and SER's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OXBDF
1D Price
Change %
OXBDF100%
N/A
SER - OXBDF
25%
Poorly correlated
-0.20%
XTLB - OXBDF
24%
Poorly correlated
-1.68%
TBPH - OXBDF
24%
Poorly correlated
+2.03%
ATNM - OXBDF
24%
Poorly correlated
+1.26%
YECO - OXBDF
22%
Poorly correlated
N/A
More